Optimi Health (TSE:OPTI)
:OPTI
Want to see TSE:OPTI full AI Analyst Report?
OPTI Stock Chart & Stats
C$0.32
>-C$0.01(-2.38%)
At close: 4:00 PM EST
C$0.32
>-C$0.01(-2.38%)
Day’s Range― - ―
52-Week RangeC$0.11 - C$0.42
Previous CloseN/A
Volume13.36K
Average Volume (3M)169.72K
Market Cap
C$32.90M
Enterprise ValueC$36.69M
Total Cash (Recent Filing)C$491.75K
Total Debt (Recent Filing)C$6.70M
Price to Earnings (P/E)―
Beta0.28
Next Earnings
May 27, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.04
Shares Outstanding96,776,920
10 Day Avg. Volume137,724
30 Day Avg. Volume169,715
Financial Highlights & Ratios
PEG Ratio0.24
Price to Book (P/B)5.70
Price to Sales (P/S)87.81
P/FCF Ratio-13.78
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Reduced Cash BurnImproved operating cash flow versus the prior year indicates management has reduced cash burn through cost control or operational adjustments. That trend, if sustained, extends runway, lowers near-term financing needs and improves the firm's ability to execute strategic initiatives over the next several months.
Positive Equity BufferA positive equity base (~5.0M) provides a tangible balance-sheet cushion for ongoing losses and working capital needs. This buffer supports short-to-medium-term operations, gives the company optionality for strategic decisions, and reduces the immediacy of financing pressure if losses moderate.
Exposure To Regulated Psychedelics MarketOperating in regulated psychedelics and functional mushroom sectors positions the company within a structural growth market with high regulatory barriers. Licensed production capabilities can create durable competitive advantages and long-term revenue potential as medical and wellness adoption progresses.
Bears Say
Severely Weak And Declining RevenueVery low and sharply declining revenue undermines scalability and the company's capacity to cover fixed costs or invest in growth. Persistent top-line weakness makes reaching breakeven harder, increases reliance on external funding, and limits the durability of operating improvements over the medium term.
Negative Margins And Persistent LossesMaterial operating losses and negative gross profit indicate fundamental unit economics problems. Sustained losses erode equity, limit reinvestment in core capabilities, and weaken the company's negotiating position with partners and lenders, increasing long-term execution and viability risk.
Rising Leverage For A Loss-making FirmSubstantially higher debt while the business is loss-making raises refinancing and covenant risk. Elevated leverage increases interest and fixed obligations, reducing financial flexibility to fund commercialization or regulatory compliance, and amplifies downside if revenues do not recover.
Optimi Health News
OPTI FAQ
What was Optimi Health’s price range in the past 12 months?
Optimi Health lowest stock price was C$0.10 and its highest was C$0.42 in the past 12 months.
What is Optimi Health’s market cap?
Optimi Health’s market cap is C$32.90M.
When is Optimi Health’s upcoming earnings report date?
Optimi Health’s upcoming earnings report date is May 27, 2026 which is in 21 days.
How were Optimi Health’s earnings last quarter?
Currently, no data Available
Is Optimi Health overvalued?
According to Wall Street analysts Optimi Health’s price is currently Overvalued.
Does Optimi Health pay dividends?
Optimi Health does not currently pay dividends.
What is Optimi Health’s EPS estimate?
Optimi Health’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Optimi Health have?
Optimi Health has 96,776,920 shares outstanding.
What happened to Optimi Health’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Optimi Health?
Currently, no hedge funds are holding shares in TSE:OPTI
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Optimi Health Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
70.45%
12-Months-Change
Fundamentals
Return on Equity
-57.28%
Trailing 12-Months
Asset Growth
1.66%
Trailing 12-Months
Company Description
Optimi Health
Optimi Health Corp. develops an integrated functional mushroom brand that focuses on the health and wellness food markets in Canada. The company also focuses on the cultivation, extraction, processing, and distribution of strains of functional mushroom. It offers a range of fungi varieties, which include Lions Mane, Reishi, Turkey Tail, Chaga, and Cordyceps. The company was formerly known as 1251418 BC Ltd. and changed its name to Optimi Health Corp. in August 2020. Optimi Health Corp. was incorporated in 2020 and is headquartered in Vancouver, Canada.
Technical Analysis
Rapid Dose Therapeutics Corp
―
MediPharm Labs
―
PharmaCielo
―
Rubicon Organics
―
Avicanna
―
Options Prices
Currently, No data available
---